What is ETH-LAD, ETHLAD 6-ethyl-6-nor-LSD
ETH-LAD, or ETHLAD, also known as 6-ethyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD; also known as METH-LAD).
It is slightly more potent than LSD and is among the most potent psychedelics known.The drug is taken orally.
It acts as a serotonin receptor agonist, including of the serotonin 5-HT2A receptor. In addition, it binds to dopamine receptors.
The drug produces psychedelic-like effects in animals. It is closely structurally related to LSD and to other psychedelic lysergamides like PRO-LAD and AL-LAD.
ETH-LAD was first described in the scientific literature by 1976. Its effects in humans were assessed and reported by Alexander Shulgin in the 1980s and 1990s.
The drug was encountered as a novel recreational designer drug in Europe by 2016. In addition, a prodrug of ETH-LAD, 1P-ETH-LAD, has been developed and encountered as a designer drug.
The effects of ETH-LAD have been reported to include closed-eye imagery, very few visual changes or distortions, gentle movements of objects, LSD-like visual aspects, two-dimensional surfaces looking three-dimensional, objects looking “magical”, and possible time slowing.
It was described as making the body feel balanced, thinking being easy, concepts easy to follow through, mind capable of realistic and down-to-earth thought, and warmth and humor being present.
Other reported effects included feeling lazy, diuretic effects, no appetite loss, decongestant effects, stomach discomfort, and chills.
Compared to LSD, ETH-LAD was described as lacking the push and sparkle of LSD, allowing for extraordinary experiences with none of LSD’s demands, being less aggressive than LSD and lacking its “taking control” nature, having a greatly modified degree of visual distortion relative to LSD, having visual effects similar to LSD but much more gentle, and being more allowing than demanding.
Reviews
There are no reviews yet.